Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	extracellular matrix constituent, lubricant activity	MUC3A MUC4	6.63e-05	4	67	2	GO:0030197
GeneOntologyCellularComponent	Golgi lumen	MUC21 ACAN VCAN MUC19 MUC16 MUC5B MUC12 MUC3A MUC4	1.16e-10	109	71	9	GO:0005796
GeneOntologyCellularComponent	perineuronal net	ACAN VCAN	5.03e-04	10	71	2	GO:0072534
GeneOntologyCellularComponent	perisynaptic extracellular matrix	ACAN VCAN	6.13e-04	11	71	2	GO:0098966
HumanPheno	Transverse vaginal septum	MKKS TP63	2.13e-05	2	24	2	HP:0000145
HumanPheno	Palate fistula	PDGFRA TP63 ARHGEF38	2.55e-05	13	24	3	HP:0010294
MousePheno	absent epidermis	TP63 VCAN	1.58e-05	2	56	2	MP:0001217
Domain	WWE	DTX1 DTX4 DTX2 HUWE1	6.48e-08	12	65	4	PS50918
Domain	WWE	DTX1 DTX4 DTX2 HUWE1	6.48e-08	12	65	4	PF02825
Domain	WWE-dom	DTX1 DTX4 DTX2 HUWE1	6.48e-08	12	65	4	IPR004170
Domain	WWE	DTX1 DTX4 DTX2	1.61e-07	4	65	3	SM00678
Domain	WWE-dom_subgr	DTX1 DTX4 DTX2	1.61e-07	4	65	3	IPR018123
Domain	Mucin_dom	MUC21 MUC22	1.19e-05	2	65	2	IPR028199
Domain	Epiglycanin_C	MUC21 MUC22	1.19e-05	2	65	2	PF14654
Domain	VWD	MUC19 MUC5B MUC4	2.18e-05	16	65	3	SM00216
Domain	VWF_type-D	MUC19 MUC5B MUC4	2.18e-05	16	65	3	IPR001846
Domain	VWFD	MUC19 MUC5B MUC4	2.18e-05	16	65	3	PS51233
Domain	VWD	MUC19 MUC5B MUC4	2.18e-05	16	65	3	PF00094
Domain	SEA	MUC16 MUC12 MUC3A	6.78e-05	23	65	3	PS50024
Domain	SEA_dom	MUC16 MUC12 MUC3A	6.78e-05	23	65	3	IPR000082
Domain	TIL	MUC19 MUC5B	7.70e-04	12	65	2	PF01826
Domain	Oxysterol-bd	OSBPL3 OSBPL11	7.70e-04	12	65	2	IPR000648
Domain	Oxysterol-bd_CS	OSBPL3 OSBPL11	7.70e-04	12	65	2	IPR018494
Domain	Oxysterol_BP	OSBPL3 OSBPL11	7.70e-04	12	65	2	PF01237
Domain	C8	MUC19 MUC5B	7.70e-04	12	65	2	PF08742
Domain	OSBP	OSBPL3 OSBPL11	7.70e-04	12	65	2	PS01013
Domain	Sushi	VCAN SEZ6L SEZ6	7.87e-04	52	65	3	PF00084
Domain	CCP	VCAN SEZ6L SEZ6	8.79e-04	54	65	3	SM00032
Domain	Unchr_dom_Cys-rich	MUC19 MUC5B	9.08e-04	13	65	2	IPR014853
Domain	C8	MUC19 MUC5B	9.08e-04	13	65	2	SM00832
Domain	SUSHI	VCAN SEZ6L SEZ6	9.78e-04	56	65	3	PS50923
Domain	Sushi_SCR_CCP_dom	VCAN SEZ6L SEZ6	1.03e-03	57	65	3	IPR000436
Domain	Znf_RING/FYVE/PHD	SH3RF2 DTX1 DTX4 KMT2A IRF2BPL DTX2 BSN	1.05e-03	459	65	7	IPR013083
Domain	SEA	MUC16 MUC3A	1.06e-03	14	65	2	SM00200
Domain	TIL_dom	MUC19 MUC5B	1.06e-03	14	65	2	IPR002919
Domain	EGF	BRINP3 FAT2 VCAN MUC3A MUC4	1.35e-03	235	65	5	SM00181
Domain	Post-SET_dom	SETDB1 KMT2A	1.39e-03	16	65	2	IPR003616
Domain	PostSET	SETDB1 KMT2A	1.39e-03	16	65	2	SM00508
Domain	POST_SET	SETDB1 KMT2A	1.39e-03	16	65	2	PS50868
Domain	CTCK_1	MUC19 MUC5B	1.76e-03	18	65	2	PS01185
Domain	EGF_1	FAT2 VCAN MUC12 MUC3A MUC4	1.93e-03	255	65	5	PS00022
Domain	VWC_out	MUC19 MUC5B	1.96e-03	19	65	2	SM00215
Domain	EGF-like_CS	FAT2 VCAN MUC12 MUC3A MUC4	2.14e-03	261	65	5	IPR013032
Domain	EGF_2	FAT2 VCAN MUC12 MUC3A MUC4	2.29e-03	265	65	5	PS01186
Domain	SEA	MUC16 MUC12	2.63e-03	22	65	2	PF01390
Domain	CT	MUC19 MUC5B	2.63e-03	22	65	2	SM00041
Domain	Znf_C3HC4_RING-type	SH3RF2 DTX1 DTX4 DTX2	3.04e-03	172	65	4	IPR018957
Domain	SH3_2	SHANK2 SH3RF2 ARHGEF38	3.35e-03	86	65	3	IPR011511
Domain	SH3_2	SHANK2 SH3RF2 ARHGEF38	3.35e-03	86	65	3	PF07653
Domain	Cys_knot_C	MUC19 MUC5B	3.40e-03	25	65	2	IPR006207
Domain	CTCK_2	MUC19 MUC5B	3.40e-03	25	65	2	PS01225
Domain	ZF_RING_1	SH3RF2 DTX1 DTX4 IRF2BPL DTX2	3.42e-03	291	65	5	PS00518
Domain	SAM	SHANK2 TP63 TNKS2	3.58e-03	88	65	3	SM00454
Domain	ZF_RING_2	SH3RF2 DTX1 DTX4 IRF2BPL DTX2	3.78e-03	298	65	5	PS50089
Domain	SAM_DOMAIN	SHANK2 TP63 TNKS2	4.43e-03	95	65	3	PS50105
Domain	-	SH3RF2 DTX1 DTX4 KMT2A DTX2 BSN	4.66e-03	449	65	6	3.30.40.10
Domain	SAM	SHANK2 TP63 TNKS2	4.70e-03	97	65	3	IPR001660
Domain	Znf_RING	SH3RF2 DTX1 DTX4 IRF2BPL DTX2	5.52e-03	326	65	5	IPR001841
Domain	-	SHANK2 TP63 TNKS2	6.01e-03	106	65	3	1.10.150.50
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC21 MUC16 MUC5B MUC12 MUC3A MUC4	1.14e-11	16	50	6	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC21 MUC16 MUC5B MUC12 MUC3A MUC4	1.75e-11	17	50	6	M27412
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC21 MUC16 MUC5B MUC12 MUC3A MUC4	1.41e-10	23	50	6	M556
Pathway	REACTOME_DECTIN_2_FAMILY	MUC21 MUC16 MUC5B MUC12 MUC3A MUC4	3.18e-10	26	50	6	M27483
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC21 MUC19 MUC16 MUC5B MUC4	8.91e-09	21	50	5	MM15706
Pathway	REACTOME_DISEASES_OF_GLYCOSYLATION	MUC21 ACAN VCAN MUC16 MUC5B MUC12 MUC3A MUC4	3.45e-08	143	50	8	M27275
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC21 MUC16 MUC5B MUC12 MUC3A MUC4	7.72e-08	62	50	6	M546
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	MUC21 MUC16 MUC5B MUC12 MUC3A MUC4	1.35e-07	68	50	6	M27303
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC21 MUC19 MUC16 MUC5B MUC4	2.16e-06	60	50	5	MM15636
Pathway	REACTOME_DISEASES_OF_METABOLISM	MUC21 ACAN VCAN MUC16 MUC5B MUC12 MUC3A MUC4	2.47e-06	250	50	8	M27554
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC21 MUC16 MUC5B MUC12 MUC3A MUC4	2.49e-06	111	50	6	M27416
Pathway	REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS	DTX1 DTX4 DTX2	4.95e-06	10	50	3	MM14849
Pathway	REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS	MUC21 MUC16 MUC5B MUC12 MUC3A MUC4	9.56e-06	140	50	6	M27484
Pathway	REACTOME_SIGNALING_BY_NOTCH1	DTX1 DTX4 DTX2	3.30e-05	18	50	3	MM14775
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC21 MUC19 MUC16 MUC5B MUC4	4.05e-05	109	50	5	MM15164
Pathway	REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS	DTX1 DTX4 DTX2	1.76e-04	31	50	3	M592
Pathway	KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PI3K_SIGNALING_PATHWAY	PDGFRA MTOR	3.41e-04	8	50	2	M47399
Pathway	REACTOME_SIGNALING_BY_NOTCH	DTX1 DTX4 DTX2	3.51e-04	39	50	3	MM14604
Pathway	WP_NOTCH_SIGNALING_WP268	DTX1 DTX4 DTX2	5.36e-04	45	50	3	M39571
Pathway	WP_NOTCH_SIGNALING_PATHWAY	DTX1 DTX4 DTX2	5.72e-04	46	50	3	MM15971
Pathway	KEGG_NOTCH_SIGNALING_PATHWAY	DTX1 DTX4 DTX2	6.10e-04	47	50	3	M7946
Pathway	KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY	PDGFRA MTOR	9.38e-04	13	50	2	M47398
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC19 MUC16 MUC5B MUC12 MUC3A MUC4	1.06e-12	18	71	6	18834073
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	TPR PAPOLA PPRC1 FMN1 OSBPL3 VCAN OSBPL11 SERINC3 DTX2 QSER1 HUWE1 ANKRD50 UBN2 WNK1 BRWD1	4.14e-09	1084	71	15	11544199
Pubmed	Cell fate determinant Llgl1 is required for propagation of acute myeloid leukemia.	LLGL1 MTOR KMT2A	8.15e-09	3	71	3	37587260
Pubmed	T cells develop normally in the absence of both Deltex1 and Deltex2.	DTX1 DTX4 DTX2	8.15e-09	3	71	3	16923970
Pubmed	Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.	MUC19 MUC16 MUC5B	1.62e-07	6	71	3	19110483
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	FAT2 CMTR1 OSBPL3 IRF2BPL DTX2 UBN2 YTHDC1 WNK1 DOP1A	7.34e-07	493	71	9	15368895
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	LPIN1 DENND4A LLGL1 OSBPL3 OSBPL11 KMT2A QSER1 ANKRD50 HCFC1 RSBN1L	8.04e-07	650	71	10	38777146
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	TPR FNBP4 OSBPL11 KMT2A QSER1 HUWE1 UBN2 HCFC1 RSBN1L	1.78e-06	549	71	9	38280479
Pubmed	O-linked N-acetylglucosamine proteomics of postsynaptic density preparations using lectin weak affinity chromatography and mass spectrometry.	SHANK2 BSN HCFC1	2.92e-06	14	71	3	16452088
Pubmed	Enoyl-CoA hydratase-1 regulates mTOR signaling and apoptosis by sensing nutrients.	MTOR SH3RF2 BRWD1	2.92e-06	14	71	3	28878358
Pubmed	Normal immune system development in mice lacking the Deltex-1 RING finger domain.	DTX1 DTX4	4.11e-06	2	71	2	15684394
Pubmed	Mucins: a biologically relevant glycan barrier in mucosal protection.	MUC21 MUC12	4.11e-06	2	71	2	24821013
Pubmed	Identification and characterization of versican/PG-M aggregates in cartilage.	ACAN VCAN	4.11e-06	2	71	2	16648631
Pubmed	Cleavage of the carboxyl tail from the G3 domain of aggrecan but not versican and identification of the amino acids involved in the degradation.	ACAN VCAN	4.11e-06	2	71	2	11932252
Pubmed	The RNA m6A reader YTHDC1 silences retrotransposons and guards ES cell identity.	SETDB1 YTHDC1	4.11e-06	2	71	2	33658714
Pubmed	Genetic evidence that formins function within the nucleus.	FMN1 FNBP4	4.11e-06	2	71	2	8798555
Pubmed	Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology.	MUC16 MUC4	4.11e-06	2	71	2	23544943
Pubmed	Expression of mucins in mucoid otitis media.	MUC5B MUC4	4.11e-06	2	71	2	14690056
Pubmed	Association of variants in FRAP1 and PDGFRA with corneal curvature in Asian populations from Singapore.	PDGFRA MTOR	4.11e-06	2	71	2	21665993
Pubmed	Membrane-bound mucin modular domains: from structure to function.	MUC21 MUC12	4.11e-06	2	71	2	23178705
Pubmed	Setdb1, a novel interactor of ΔNp63, is involved in breast tumorigenesis.	SETDB1 TP63	4.11e-06	2	71	2	26840455
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	TPR OSBPL11 NAV2 TMF1 HUWE1 YTHDC1 WNK1 HCFC1	8.67e-06	503	71	8	16964243
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	RALGAPA1 DENND4A PDGFRA MTOR OSBPL3 NAV2 KMT2A RFX7 WNK1 DOP1A	9.69e-06	861	71	10	36931259
Pubmed	Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model.	MUC16 MUC4	1.23e-05	3	71	2	23053434
Pubmed	The m6A reader YTHDC1 regulates muscle stem cell proliferation via PI4K-Akt-mTOR signalling.	MTOR YTHDC1	1.23e-05	3	71	2	36722312
Pubmed	Link protein has greater affinity for versican than aggrecan.	ACAN VCAN	1.23e-05	3	71	2	14724283
Pubmed	Topographical variation in the distributions of versican, aggrecan and perlecan in the foetal human spine reflects their diverse functional roles in spinal development.	ACAN VCAN	1.23e-05	3	71	2	19669783
Pubmed	Expression and purification of functionally active hyaluronan-binding domains from human cartilage link protein, aggrecan and versican: formation of ternary complexes with defined hyaluronan oligosaccharides.	ACAN VCAN	1.23e-05	3	71	2	15590670
Pubmed	Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.	MUC16 MUC4	1.23e-05	3	71	2	30236127
Pubmed	MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism.	MTOR MUC16	1.23e-05	3	71	2	26046375
Pubmed	ΔNp63α induces the expression of FAT2 and Slug to promote tumor invasion.	FAT2 TP63	1.23e-05	3	71	2	27081041
Pubmed	Lipid signalling drives proteolytic rewiring of mitochondria by YME1L.	LPIN1 MTOR	1.23e-05	3	71	2	31695197
Pubmed	E2F1 mediates DNA damage and apoptosis through HCF-1 and the MLL family of histone methyltransferases.	KMT2A HCFC1	1.23e-05	3	71	2	19763085
Pubmed	Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis.	MUC16 MUC12	1.23e-05	3	71	2	26770020
Pubmed	Promoting effect of PAX5-activated lncRNA UASR1 on growth of colorectal cancer by regulating the mTOR pathway.	MTOR PAX5	1.23e-05	3	71	2	32271416
Pubmed	Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican.	ACAN VCAN	1.23e-05	3	71	2	10400671
Pubmed	Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling).	MUC16 MUC4	1.23e-05	3	71	2	27483328
Pubmed	MicroRNA-200c modulates the expression of MUC4 and MUC16 by directly targeting their coding sequences in human pancreatic cancer.	MUC16 MUC4	1.23e-05	3	71	2	24204560
Pubmed	The coactivator host cell factor-1 mediates Set1 and MLL1 H3K4 trimethylation at herpesvirus immediate early promoters for initiation of infection.	KMT2A HCFC1	1.23e-05	3	71	2	17578910
Pubmed	Expression of the transmembrane mucins, MUC1, MUC4 and MUC16, in normal endometrium and in endometriosis.	MUC16 MUC4	1.23e-05	3	71	2	24939955
Pubmed	Proteasome inhibitors evoke latent tumor suppression programs in pro-B MLL leukemias through MLL-AF4.	KMT2A PAX5	1.23e-05	3	71	2	24735925
Pubmed	PDGF (alpha)-receptor is unresponsive to PDGF-AA in aortic smooth muscle cells from the NG2 knockout mouse.	PDGFRA VCAN	1.23e-05	3	71	2	10036240
Pubmed	Distinct interaction of versican/PG-M with hyaluronan and link protein.	ACAN VCAN	1.23e-05	3	71	2	12888576
Pubmed	Expression of mucin (MUC) genes in mucoepidermoid carcinoma.	MUC19 MUC4	1.23e-05	3	71	2	21072847
Pubmed	DUSP28 links regulation of Mucin 5B and Mucin 16 to migration and survival of AsPC-1 human pancreatic cancer cells.	MUC16 MUC5B	1.23e-05	3	71	2	27230679
Pubmed	In situ hybridization and immunohistochemistry of versican, aggrecan and link protein, and histochemistry of hyaluronan in the developing mouse limb bud cartilage.	ACAN VCAN	1.23e-05	3	71	2	14620382
Pubmed	Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone.	MUC16 MUC4	1.23e-05	3	71	2	17592322
Pubmed	Analysis of exome-sequenced UK Biobank subjects implicates genes affecting risk of hyperlipidaemia.	HUWE1 PCSK9	1.23e-05	3	71	2	32747172
Pubmed	Potassium acts through mTOR to regulate its own secretion.	MTOR WNK1	1.23e-05	3	71	2	31013253
Pubmed	Massive aggrecan and versican accumulation in thoracic aortic aneurysm and dissection.	ACAN VCAN	1.23e-05	3	71	2	29515038
Pubmed	PGC-1-related coactivator complexes with HCF-1 and NRF-2beta in mediating NRF-2(GABP)-dependent respiratory gene expression.	PPRC1 HCFC1	1.23e-05	3	71	2	18343819
Pubmed	Recurrent YAP1 and KMT2A Gene Rearrangements in a Subset of MUC4-negative Sclerosing Epithelioid Fibrosarcoma.	KMT2A MUC4	1.23e-05	3	71	2	31592798
Pubmed	Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection.	MUC16 MUC4	1.23e-05	3	71	2	35879412
Pubmed	Molecular cloning of two novel mucin-like genes in the disease-susceptibility locus for diffuse panbronchiolitis.	MUC21 MUC22	1.23e-05	3	71	2	20981447
Pubmed	Phosphorylation of lipin 1 and charge on the phosphatidic acid head group control its phosphatidic acid phosphatase activity and membrane association.	LPIN1 MTOR	1.23e-05	3	71	2	23426360
Pubmed	Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons.	SEZ6L SEZ6	1.23e-05	3	71	2	27716410
Pubmed	Nucleoporin TPR (translocated promoter region, nuclear basket protein) upregulation alters MTOR-HSF1 trails and suppresses autophagy induction in ependymoma.	TPR MTOR	1.23e-05	3	71	2	32207633
Pubmed	Deltex acts as a positive regulator of Notch signaling through interactions with the Notch ankyrin repeats.	DTX1 DTX2	2.46e-05	4	71	2	7671825
Pubmed	CMPK1 and RBP3 are associated with corneal curvature in Asian populations.	PDGFRA MTOR	2.46e-05	4	71	2	24963161
Pubmed	TRPV4 activation in human corneal epithelial cells promotes membrane mucin production.	MUC16 MUC4	2.46e-05	4	71	2	39024979
Pubmed	Murine homologs of deltex define a novel gene family involved in vertebrate Notch signaling and neurogenesis.	DTX1 DTX2	2.46e-05	4	71	2	11226752
Pubmed	Rheb1 promotes tumor progression through mTORC1 in MLL-AF9-initiated murine acute myeloid leukemia.	MTOR KMT2A	2.46e-05	4	71	2	27071307
Pubmed	Lecticans: organizers of the brain extracellular matrix.	ACAN VCAN	2.46e-05	4	71	2	10766023
Pubmed	Partially redundant functions of Adamts1 and Adamts4 in the perinatal development of the renal medulla.	ACAN VCAN	2.46e-05	4	71	2	21584905
Pubmed	DELTEX2 C-terminal domain recognizes and recruits ADP-ribosylated proteins for ubiquitination.	DTX1 DTX4 DTX2	2.57e-05	28	71	3	32937373
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TPR PAPOLA FNBP4 OSBPL11 KMT2A IRF2BPL HUWE1 RFX7 YTHDC1	2.78e-05	774	71	9	15302935
Pubmed	The ubiquitin ligase Uhrf2 is a master regulator of cholesterol biosynthesis and is essential for liver regeneration.	TPR KMT2A HCFC1 BRWD1	2.98e-05	86	71	4	37253089
Pubmed	Polymorphism of human mucin genes in chest disease: possible significance of MUC2.	MUC5B MUC4	4.09e-05	5	71	2	11062147
Pubmed	Proteolytically cleaved MLL subunits are susceptible to distinct degradation pathways.	KMT2A HCFC1	4.09e-05	5	71	2	21670200
Pubmed	The proteoglycans aggrecan and Versican form networks with fibulin-2 through their lectin domain binding.	ACAN VCAN	4.09e-05	5	71	2	11038354
Pubmed	OSBP-related proteins (ORPs) in human adipose depots and cultured adipocytes: evidence for impacts on the adipocyte phenotype.	OSBPL3 OSBPL11	4.09e-05	5	71	2	23028956
Pubmed	Role of Deltex-1 as a transcriptional regulator downstream of the Notch receptor.	DTX1 DTX2	4.09e-05	5	71	2	11564735
Pubmed	The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1.	RALGAPA1 LLGL1 OSBPL11 MYOM2 RSBN1L	5.33e-05	197	71	5	20811636
Pubmed	mTORC1 signaling facilitates differential stem cell differentiation to shape the developing murine lung and is associated with mitochondrial capacity.	PDGFRA MTOR TP63	6.03e-05	37	71	3	36433959
Pubmed	Adamts5, the gene encoding a proteoglycan-degrading metalloprotease, is expressed by specific cell lineages during mouse embryonic development and in adult tissues.	ACAN VCAN	6.13e-05	6	71	2	19250981
Pubmed	Over-expression of the chondroitin sulphate proteoglycan versican is associated with defective neural crest migration in the Pax3 mutant mouse (splotch).	ACAN VCAN	6.13e-05	6	71	2	9486530
Pubmed	SHP-2/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A/ARF aberrations in mice and humans.	PDGFRA MTOR	6.13e-05	6	71	2	21393858
Pubmed	Mesenchymal stromal cell-derived septoclasts resorb cartilage during developmental ossification and fracture healing.	PDGFRA ACAN	6.13e-05	6	71	2	35091558
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	FNBP4 NAV2 KMT2A MYOM2 MUC4 HCFC1 RSBN1L	7.05e-05	497	71	7	36774506
Pubmed	Association analysis of 33 lipoprotein candidate genes in multi-generational families of African ancestry.	LPIN1 PCSK9	8.57e-05	7	71	2	20308432
Pubmed	E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases.	KMT2A HCFC1	8.57e-05	7	71	2	17612494
Pubmed	Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitors.	ACAN VCAN	8.57e-05	7	71	2	21976490
Pubmed	Activation of C1r by proteolytic cleavage.	IGLV2-33 IGLV2-23 IGLV2-18	9.49e-05	43	71	3	1249422
Pubmed	Impact of WIN site inhibitor on the WDR5 interactome.	MTOR KMT2A HCFC1	9.49e-05	43	71	3	33472061
Pubmed	Cryo-EM structure of the human MLL1 core complex bound to the nucleosome.	KMT2A HCFC1	1.14e-04	8	71	2	31804488
Pubmed	The BAL-binding protein BBAP and related Deltex family members exhibit ubiquitin-protein isopeptide ligase activity.	DTX1 DTX2	1.14e-04	8	71	2	12670957
Pubmed	Divergent hTAFII31-binding motifs hidden in activation domains.	KMT2A HCFC1	1.14e-04	8	71	2	10821850
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	RALGAPA1 SETDB1 TMF1 QSER1 HUWE1 WNK1 HCFC1 RSBN1L	1.24e-04	733	71	8	34672954
Pubmed	Physicochemical and functional characterization of the C1r subunit of the first complement component.	IGLV2-33 IGLV2-23 IGLV2-18	1.24e-04	47	71	3	814163
Pubmed	Dosage-dependent transcriptional regulation by the calcineurin/NFAT signaling in developing myocardium transition.	DTX1 TP63 MYOM2	1.24e-04	47	71	3	17198697
Pubmed	Recognition of immunoglobulins by Fcgamma receptors.	IGLV2-33 IGLV2-23 IGLV2-18	1.32e-04	48	71	3	11955599
Pubmed	Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression.	KMT2A HCFC1	1.47e-04	9	71	2	15199122
Pubmed	Probing chromatin landscape reveals roles of endocardial TBX20 in septation.	PDGFRA VCAN	1.83e-04	10	71	2	27348591
Pubmed	Crosstalk between NSL histone acetyltransferase and MLL/SET complexes: NSL complex functions in promoting histone H3K4 di-methylation activity by MLL/SET complexes.	KMT2A HCFC1	1.83e-04	10	71	2	24244196
Pubmed	Chromatin accessibility complex subunit 1 enhances tumor growth by regulating the oncogenic transcription of YAP in breast and cervical cancer.	TPR HUWE1 HCFC1	2.20e-04	57	71	3	38223760
Pubmed	Versican facilitates chondrocyte differentiation and regulates joint morphogenesis.	ACAN VCAN	2.23e-04	11	71	2	20404343
Pubmed	Foxn4 influences alveologenesis during lung development.	PDGFRA TP63	2.23e-04	11	71	2	21438071
Pubmed	PDGF Signaling in Primitive Endoderm Cell Survival Is Mediated by PI3K-mTOR Through p53-Independent Mechanism.	PDGFRA MTOR	2.23e-04	11	71	2	30913328
Pubmed	Homology and the evolution of vocal folds in the novel avian voice box.	PDGFRA VCAN	2.23e-04	11	71	2	38183987
Pubmed	The OSBP-related protein family in humans.	OSBPL3 OSBPL11	2.23e-04	11	71	2	11483621
Cytoband	22q11.2	IGLV2-33 IGLV2-23 IGLV2-18	8.74e-04	120	71	3	22q11.2
Cytoband	7q22	MUC12 MUC3A	1.60e-03	38	71	2	7q22
GeneFamily	CD molecules\|Mucins	MUC21 MUC19 MUC16 MUC5B MUC12 MUC22 MUC3A MUC4	3.76e-16	21	50	8	648
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	ACAN VCAN SEZ6L SEZ6	1.83e-05	57	50	4	1179
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	ACAN VCAN	4.48e-05	4	50	2	574
GeneFamily	Oxysterol binding proteins\|Pleckstrin homology domain containing	OSBPL3 OSBPL11	4.86e-04	12	50	2	670
GeneFamily	Immunoglobulin lambda locus at 22q11.2	IGLV2-33 IGLV2-23 IGLV2-18	1.91e-03	89	50	3	353
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	SETDB1 KMT2A	3.97e-03	34	50	2	487
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	ACAN VCAN	5.74e-03	41	50	2	1298
Coexpression	NABA_ECM_AFFILIATED	MUC21 MUC19 MUC16 MUC5B MUC12 MUC22 MUC3A MUC4	1.41e-08	170	68	8	M5880
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	LPIN1 DACT1 SLC39A12 FAT2 SHANK2 VCAN MUC19 IRF2BPL PAX5 BSN RFX7 UBN2 SEZ6L DOP1A BRWD1	1.18e-07	1106	68	15	M39071
Coexpression	NABA_MATRISOME	MUC21 BRINP3 ACAN VCAN MUC19 MUC16 MUC5B MUC12 MUC22 MUC3A MUC4 HCFC1	1.17e-05	1026	68	12	M5889
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBGABA	LPIN1 DACT1 BRINP3 SHANK2 MUC19 PAX5 BSN UBN2 DOP1A SEZ6	1.29e-05	703	68	10	M39070
Coexpression	NABA_MATRISOME_ASSOCIATED	MUC21 BRINP3 MUC19 MUC16 MUC5B MUC12 MUC22 MUC3A MUC4 HCFC1	2.28e-05	751	68	10	M5885
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBML5	LPIN1 DACT1 SHANK2 MUC19 IRF2BPL PAX5 BSN UBN2	2.69e-05	465	68	8	M39066
Coexpression	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	SETDB1 LLGL1 CMTR1 PPRC1 MTOR FNBP4 HCFC1	2.75e-05	338	68	7	M17094
Coexpression	LEE_AGING_NEOCORTEX_DN	PAPOLA MTOR HCFC1 SEZ6	2.98e-05	68	68	4	M1497
Coexpression	LEE_AGING_NEOCORTEX_DN	PAPOLA MTOR HCFC1 SEZ6	5.65e-05	80	68	4	MM646
Coexpression	NABA_ECM_AFFILIATED	MUC21 MUC19 MUC16 MUC5B MUC4	5.73e-05	158	68	5	MM17063
Coexpression	HALLMARK_NOTCH_SIGNALING	DTX1 DTX4 DTX2	7.85e-05	32	68	3	M5903
Coexpression	DESCARTES_ORGANOGENESIS_EPITHELIAL_CELLS	FAT2 SH3RF2 OSBPL3 TP63 ARHGEF38	9.29e-05	175	68	5	MM3643
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	RALGAPA1 TPR LPIN1 DENND4A PAPOLA FNBP4 TMF1 KMT2A HUWE1 RFX7 YTHDC1 WNK1 BRWD1	1.04e-04	1492	68	13	M40023
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_2_CELL	VCAN ARHGEF38 MUC16 MUC5B DTX2 MUC4	1.31e-04	301	68	6	M45708
Coexpression	GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_UP	DACT1 ACAN TP63 FNBP4 MUC3A	1.66e-04	198	68	5	M3200
Coexpression	GSE17721_CTRL_VS_PAM3CSK4_1H_BMDC_DN	TPR PDGFRA VCAN YTHDC1 BRWD1	1.70e-04	199	68	5	M3731
Coexpression	GSE17721_0.5H_VS_24H_POLYIC_BMDC_DN	SETDB1 CMTR1 FNBP4 OSBPL11 QSER1	1.70e-04	199	68	5	M4097
Coexpression	GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_UP	RALGAPA1 LPIN1 DACT1 DENND4A DOP1A	1.74e-04	200	68	5	M8042
Coexpression	GSE27786_LIN_NEG_VS_BCELL_DN	CMTR1 OSBPL11 TMF1 KMT2A DTX2	1.74e-04	200	68	5	M4768
Coexpression	GSE18893_TCONV_VS_TREG_2H_CULTURE_UP	SETDB1 MTOR FAM210B DTX2 BRWD1	1.74e-04	200	68	5	M7301
Coexpression	LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE	RALGAPA1 FMN1 OSBPL3 NAV2 WNK1	2.08e-04	208	68	5	M39233
Coexpression	ZENG_GU_ICB_CONTROL_METAGENE_3_PRECICTIVE_ICB_RESPONSE	SLC39A12 PDGFRA MUC19 HUWE1 WNK1	2.23e-04	211	68	5	MM17081
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND4A CMTR1 MTOR BSN MUC4 SEZ6L DOP1A	1.12e-08	174	70	7	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	AT2_cells-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	MUC21 FAM210B NAV2 MUC5B ANKRD50 MUC3A MUC4	2.63e-08	197	70	7	5e0d222872a25bb9e9069d3dffda2844bb69874a
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBXL7 PDGFRA ACAN DTX1 VCAN SEZ6	3.17e-07	173	70	6	2b448acd5e584f24567204c31b8d74715e92f32a
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBXL7 PDGFRA ACAN DTX1 VCAN SEZ6	3.17e-07	173	70	6	5086edc29c5a6137ca09877929a1317f9739c801
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAT2 LLGL1 SH3RF2 MUC16 MUC3A MUC4	3.28e-07	174	70	6	207aa0118633cbe9a65839bbb1bb3ba9f8118ad2
ToppCell	COVID-19-kidney-DCT\|kidney / Disease (COVID-19 only), tissue and cell type	FMN1 OSBPL3 ARHGEF38 ALPK3 NAV2 WNK1	5.16e-07	188	70	6	df1fd0819d301679f3c9ea404e942e39095912eb
ToppCell	COVID-19-lung-Secretory\|lung / Disease (COVID-19 only), tissue and cell type	FAT2 SHANK2 TP63 ARHGEF38 MUC5B MUC4	5.32e-07	189	70	6	84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25
ToppCell	COVID-19-lung-Secretory\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FAT2 SHANK2 TP63 ARHGEF38 MUC5B MUC4	5.84e-07	192	70	6	59261098ccb52306f837f632ebaea45b90ad30fe
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAV2 KMT2A HUWE1 TNKS2 SEZ6L PCSK9	6.39e-07	195	70	6	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SHANK2 DTX4 MUC16 MUC5B DTX2 MUC4	6.98e-07	198	70	6	fab3135f03cf23a9f04f0eed543a9dc181f39f5f
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_secretory\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGEF38 NAV2 MUC16 MUC5B DTX2 MUC4	7.19e-07	199	70	6	7223f853335492ca617dbec3e4b6872a8a463a45
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SHANK2 MUC16 MUC5B DTX2 MUC4	5.53e-06	161	70	5	2d63b279d9a5132e1c09b03930bf9039036d24a2
ToppCell	5'-Adult-Distal_Rectal-Epithelial-goblet-BEST2+_Goblet_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NAV2 MUC5B MUC12 MUC4 PCSK9	8.29e-06	175	70	5	019ea30ac55748463d7917abf3d3f0e804189bfd
ToppCell	5'-Adult-Distal_Rectal-Epithelial-goblet\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NAV2 MUC5B MUC12 MUC4 PCSK9	9.00e-06	178	70	5	9099b47e0756d6a1b7ba1c6aa7b47c5425f649e0
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MUC21 SHANK2 ARHGEF38 NAV2 MUC4	9.51e-06	180	70	5	b509c7d6bdfba672065fb722874bdc68de72ba1c
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	MUC21 SHANK2 ARHGEF38 NAV2 MUC4	9.76e-06	181	70	5	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SHANK2 MUC16 MUC5B DTX2 MUC4	1.00e-05	182	70	5	3f1a666fe27dd7529c114539ed5f6b8ca585c875
ToppCell	Epithelial-lung_goblet_cell\|World / Lineage, Cell type, age group and donor	SHANK2 MUC16 MUC5B DTX2 MUC4	1.03e-05	183	70	5	940cbe298e9c53b5622af09264586ed823d3141f
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRINP3 PDGFRA ACAN VCAN SEZ6L	1.06e-05	184	70	5	278a7ed764c326450cb70e69ed2175980eaf5fe0
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRINP3 PDGFRA ACAN VCAN SEZ6L	1.06e-05	184	70	5	8d86e125257ff1d3af8d90577a8b3f0321eca21c
ToppCell	pdx-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	FBXL7 FMN1 VCAN NAV2 SEZ6L	1.14e-05	187	70	5	7e376831a11ee72ed87abcdac631ca46ae29c250
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRINP3 PDGFRA ACAN VCAN SEZ6L	1.17e-05	188	70	5	7471c194276161422326647f09022e94f3d1640c
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SHANK2 SH3RF2 NAV2 MUC4 PCSK9	1.17e-05	188	70	5	43a3a59f92ad93509d4166bd025aed0b1b39a008
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRINP3 PDGFRA ACAN VCAN SEZ6L	1.17e-05	188	70	5	053c251d3ddbeb866f34565aefca4535517b4387
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FMN1 OSBPL3 ARHGEF38 NAV2 WNK1	1.20e-05	189	70	5	f51cdc9a47371cab8ed9ae63a6f14da07ede446c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRINP3 OSBPL3 ARHGEF38 NAV2 WNK1	1.20e-05	189	70	5	55420853f730b433ef58ac9337ac84ac78a247a0
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRINP3 PDGFRA VCAN SEZ6L SEZ6	1.23e-05	190	70	5	9b825b2586c7b173ff27fcf2abc5860faf50984a
ToppCell	COVID-19-Epithelial_cells-Airway_goblet\|COVID-19 / group, cell type (main and fine annotations)	SHANK2 ARHGEF38 MUC16 MUC5B MUC4	1.23e-05	190	70	5	51ca9ef4df3220487152fcf684147730637c7cc1
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRINP3 PDGFRA VCAN SEZ6L SEZ6	1.23e-05	190	70	5	d146af1926474328a7c822bc140c4dda66e1bbfb
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND4A OSBPL11 TMF1 SERINC3 TNKS2	1.33e-05	193	70	5	06b65110db974f4ef90d3511ff34428976a52c9c
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND4A OSBPL11 TMF1 SERINC3 TNKS2	1.33e-05	193	70	5	9c16032bc03df8760ae199e8f19fdafa4c3f1827
ToppCell	Club_cells-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	FAT2 DTX4 MUC16 MUC5B MUC4	1.33e-05	193	70	5	6582c0367052b9d10fb629c383ee0c55872afd2d
ToppCell	facs-Brain_Myeloid-Hippocampus-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND4A OSBPL11 TMF1 SERINC3 TNKS2	1.33e-05	193	70	5	a4f91bca5eaa985982d33a528f7566ffde154d47
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND4A OSBPL11 TMF1 SERINC3 TNKS2	1.33e-05	193	70	5	b39d7feaac4ff8f7409cd3d15e8f3c6391367275
ToppCell	IPF-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	SHANK2 DNAH10 NAV2 MUC5B MUC4	1.40e-05	195	70	5	21dbdc803c6947024dc2416e9e21c2ef0af9bc31
ToppCell	Epithelial_cells-Club_cells\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	DTX4 MUC16 MUC5B DTX2 MUC4	1.40e-05	195	70	5	b758676abfc4e6930b696d270ecc0ea461b87a54
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SHANK2 MUC16 MUC5B DTX2 MUC4	1.40e-05	195	70	5	e7230a849ea31e6eef9bc6f5468938499450582d
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAV2 KMT2A HUWE1 SEZ6L PCSK9	1.40e-05	195	70	5	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	Bronchus_Control_(B.)\|World / Sample group, Lineage and Cell type	SH3RF2 MUC16 MUC5B PAX5 MUC4	1.47e-05	197	70	5	b6dff2ee108813e18657e2d8cf850e2423f8c8e9
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Suprabasal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	FAT2 TP63 MUC16 MUC5B MUC4	1.51e-05	198	70	5	de5987588b9fa9ee8c595ba06d7d844ead0e3c74
ToppCell	LPS_only-Epithelial_airway-airway_epithelial-Airway-Club\|LPS_only / Treatment groups by lineage, cell group, cell type	SH3RF2 TP63 NAV2 MUC5B MUC4	1.54e-05	199	70	5	165ac94b2d56072ad43358b5127d77555221e2d8
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DTX4 MUC16 MUC5B DTX2 MUC4	1.58e-05	200	70	5	b992eeddee38e6fe3564e9b1850f6b20b89bf47d
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SHANK2 FMN1 ARHGEF38 MUC16 MUC5B	1.58e-05	200	70	5	c450a15e21fa72d071ed6e3b9f22de557a0f3cea
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SHANK2 ARHGEF38 MUC16 MUC5B DTX2	1.58e-05	200	70	5	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SHANK2 FMN1 ARHGEF38 MUC16 MUC5B	1.58e-05	200	70	5	0eb9ad8c0373bcc62029ec21c590ed03aaacd039
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2-Mgp\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	FAT2 FBXL7 SH3RF2 MYOM2	4.38e-05	124	70	4	b0ed84522180f8cea541461faf7882c57abf8cd4
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	FAT2 FBXL7 SH3RF2 MYOM2	4.38e-05	124	70	4	231862f849d8ab73c6a44c782d33ef2f07661baf
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Airway\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH10 DTX4 ARHGEF38 SEZ6L	4.38e-05	124	70	4	a7b7d8b14d1218194da8fcf69b4780b6e9469332
ToppCell	Bronchial-10x5prime-Hematologic-Erythrocyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGLV2-23 FAM210B SEZ6L SEZ6	4.66e-05	126	70	4	65c7c0e4cfb5ac58d80b4034d42e9f662116e0d3
ToppCell	Bronchial-10x5prime-Hematologic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGLV2-23 FAM210B SEZ6L SEZ6	4.66e-05	126	70	4	b6482ef18e6d9e12ba4810ce7845f9f991cb95bc
ToppCell	Bronchial-10x5prime-Hematologic-Erythrocyte-Erythrocyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGLV2-23 FAM210B SEZ6L SEZ6	4.66e-05	126	70	4	12f3d0f60db462f2a9799b3a06005bc871670760
ToppCell	Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_endoneurial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	DACT1 PDGFRA MUC12 DOP1A	8.04e-05	145	70	4	e808502fa52baf1c400f3c9b918a167127e78af9
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SH3RF2 ARHGEF38 NAV2 MUC4	8.71e-05	148	70	4	9fe3c0a5904b8e9a0f28130f8d84d4f2a819b06c
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FMN1 ALPK3 NAV2 WNK1	1.07e-04	156	70	4	4d2679e7639758c49fc25a2deb9109b08f0a3e57
ToppCell	TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue-4\|TCGA-Stomach / Sample_Type by Project: Shred V9	MUC21 FAT2 TP63 MUC22	1.09e-04	157	70	4	2553ebf3e48de5bd184e77bd61114faa5a1d95ed
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6\|TCGA-Stomach / Sample_Type by Project: Shred V9	PPRC1 OSBPL3 MUC4 HCFC1	1.15e-04	159	70	4	655c0749c238bd68cb797adb83e25a23b8a3cc9d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DACT1 ACAN VCAN NAV2	1.21e-04	161	70	4	a7e09cf2ca6cd70d40d08440fe9c5ab9befa1b79
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DACT1 ACAN VCAN NAV2	1.21e-04	161	70	4	08920a716f6ec62538e361211455a30ad726d7be
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SHANK2 SH3RF2 ARHGEF38 NAV2	1.23e-04	162	70	4	5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-4\|TCGA-Stomach / Sample_Type by Project: Shred V9	MUC21 FAT2 TP63 MUC22	1.26e-04	163	70	4	6a12b802cb181f979ebc72674f3626fb855024e3
ToppCell	3'-Adult-SmallIntestine-Hematopoietic-B_cells-Cycling_B_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LPIN1 IGLV2-18 DTX1 PAX5	1.45e-04	169	70	4	203971cceeba150d0e8891c92662545e84c77837
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet-Goblet_cell\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SH3RF2 ARHGEF38 MUC5B MUC4	1.49e-04	170	70	4	2c5a1469e5743870e96e6c2cc92f0c5096b79f51
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SH3RF2 ARHGEF38 MUC5B MUC4	1.49e-04	170	70	4	9bea81031cdfe45e8cddac3a3afd9ca6c331c45a
ToppCell	facs-Trachea-nan-24m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SH3RF2 TP63 MUC5B MUC4	1.52e-04	171	70	4	d2a10e94b0490120d1420b944302eb841f902c64
ToppCell	TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Head_and_Neck-Head_and_Neck_normal_tissue-5\|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9	MUC21 DNAH10 MUC16 MUC22	1.55e-04	172	70	4	6b8a8d3b97c10b9d092307eed3cacbd2745df185
ToppCell	droplet-Lung-nan-3m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DTX1 SERINC3 PAX5 BRWD1	1.59e-04	173	70	4	25d72fa7a84baf5660ead6da67327590f5c91860
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_2\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	FAT2 MUC16 MUC5B MUC4	1.59e-04	173	70	4	d1e47c87bd4750801f3531f66a56c5dccb4ea64c
ToppCell	droplet-Lung-nan-3m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DTX1 SERINC3 PAX5 BRWD1	1.59e-04	173	70	4	886ac1b98f709ad7131df778b83712bf8ed313de
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	FAT2 TP63 MUC16 MUC4	1.62e-04	174	70	4	9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC21 MUC16 MUC22 MUC4	1.66e-04	175	70	4	8252ddc2ca95071381f0354aefb70c4714828491
ToppCell	368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	MUC21 SH3RF2 ARHGEF38 PCSK9	1.66e-04	175	70	4	fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SH3RF2 OSBPL3 ARHGEF38 MUC3A	1.66e-04	175	70	4	6759d200a133034756de9cdf2d5daceca927aac9
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND4A OSBPL11 SERINC3 WNK1	1.66e-04	175	70	4	1ea6cf9da26601646f57fa14d558a5e9e1f0b345
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC21 MUC16 MUC22 MUC4	1.66e-04	175	70	4	8ccf60fc469059d7aaf4e6ce54159db2962e0060
ToppCell	368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)\|368C / Donor, Lineage, Cell class and subclass (all cells)	MUC21 SH3RF2 ARHGEF38 PCSK9	1.66e-04	175	70	4	36c140540497bbe1c5f08fac2d94f08cac18fabb
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	FAT2 SH3RF2 MUC16 MUC4	1.70e-04	176	70	4	8d9d0fb46c418b2067be58aec822e8c2b1561461
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRINP3 PDGFRA VCAN SEZ6L	1.70e-04	176	70	4	ef0ff02897104e938c8a632357d8f1a6f014e68a
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRINP3 PDGFRA VCAN SEZ6L	1.70e-04	176	70	4	da0983929fa682a68e536c298a2d7add188b7563
ToppCell	Control-Lymphoid_P-Plasmablast\|Control / Disease group, lineage and cell class	IGLV2-33 IGLV2-23 IGLV2-18 TP63	1.70e-04	176	70	4	4b4416f342b732d2cc60133838728880326257d8
ToppCell	Control-Lymphoid_P\|Control / Disease group, lineage and cell class	IGLV2-33 IGLV2-23 IGLV2-18 TP63	1.70e-04	176	70	4	d895a6b295cd649273ff80ad7785a3e0ae4c728a
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SHANK2 ARHGEF38 NAV2 MUC4	1.70e-04	176	70	4	3bbac5c2397535631fce8fa98f6ddb4fe0260351
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IGLV2-33 IGLV2-23 IGLV2-18 TP63	1.73e-04	177	70	4	4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGLV2-33 IGLV2-23 IGLV2-18 TP63	1.73e-04	177	70	4	d746122bf8d208c3aa4d156e8c12d0a0e555c6e5
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGLV2-33 IGLV2-23 IGLV2-18 TP63	1.73e-04	177	70	4	fc40918825b7e1eb6861df59dfca944778a64b98
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-basal_proximal\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	FAT2 SH3RF2 TP63 MUC4	1.77e-04	178	70	4	9534c4f4e950bb1498c1737ca1713e7f37d0aff2
ToppCell	Adult-Epithelial-club_cell-D122\|Adult / Lineage, Cell type, age group and donor	SHANK2 ARHGEF38 DTX2 MUC4	1.77e-04	178	70	4	35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGLV2-33 IGLV2-23 IGLV2-18 TP63	1.81e-04	179	70	4	837ed81f18257f444eaeadc4fac89deedd4e3061
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARHGEF38 MUC16 MUC5B MUC4	1.81e-04	179	70	4	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	nucseq-Epithelial-Epithelial_Glandular\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC16 MUC5B MUC3A MUC4	1.81e-04	179	70	4	859cd8ee414ad6207c046ada2e655e49322dd01c
ToppCell	droplet-Liver-LIVER_HEP-30m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SH3RF2 PAX5 MUC4 SEZ6L	1.81e-04	179	70	4	4135f9e8cd8494cbc189e5210dded84659643fb8
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGLV2-33 IGLV2-23 IGLV2-18 TP63	1.81e-04	179	70	4	494febe77c6d4e6a2c6f0928bbf4c84b0301f188
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHANK2 SH3RF2 OSBPL3 NAV2	1.81e-04	179	70	4	04ce3673e46606f63d9c87bcba3a64c96817d812
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGLV2-33 IGLV2-23 IGLV2-18 TP63	1.81e-04	179	70	4	b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRINP3 PDGFRA ACAN VCAN	1.85e-04	180	70	4	fa819df81fca95c2cc602fede635cb03e3f35fad
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FMN1 OSBPL3 DTX1 ARHGEF38	1.85e-04	180	70	4	9e09b3dfe344b5d50520711513d389865d73a861
ToppCell	facs-Marrow-B-cells-3m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DACT1 BRINP3 PCSK9 SEZ6	1.85e-04	180	70	4	c54af6fb11484dacd3efa1f10a487376ff820a5e
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRINP3 PDGFRA ACAN VCAN	1.85e-04	180	70	4	907cd510fd2e21532ce04ba687e8894f7af71f27
ToppCell	nucseq-Epithelial-Epithelial_Glandular-Goblet\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC16 MUC5B MUC3A MUC4	1.85e-04	180	70	4	3dc80bc636bf0e6ffc9762853132a9fe59fd1f66
ToppCell	nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC16 MUC5B MUC3A MUC4	1.85e-04	180	70	4	668a2d8e1d5a390309d5eb62c836f5903144bea9
ToppCell	facs-Marrow-B-cells-3m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DACT1 BRINP3 PCSK9 SEZ6	1.85e-04	180	70	4	07ac979b21be2425294d9818c48b5a1e6f014c19
Drug	ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A	TPR SETDB1 PDGFRA OSBPL3 KMT2A WNK1 BRWD1	1.54e-06	195	66	7	6918_UP
Drug	guanidine hydrochloride	DACT1 ACAN VCAN MUC12 MUC3A MUC4	2.02e-06	129	66	6	CID000005742
Drug	Mometasone furoate [83919-23-7]; Down 200; 7.6uM; PC3; HT_HG-U133A	FBXL7 DTX4 VCAN FAM210B MUC5B QSER1	1.76e-05	188	66	6	5116_DN
Drug	Coralyne chloride hydrate [38989-38-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A	DENND4A FBXL7 LLGL1 TP63 FAM210B HCFC1	2.10e-05	194	66	6	5418_UP
Drug	Bromocryptine mesylate [22260-51-1]; Up 200; 5.4uM; MCF7; HT_HG-U133A	LPIN1 PDGFRA PAX5 QSER1 HUWE1 HCFC1	2.17e-05	195	66	6	5665_UP
Drug	Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; PC3; HT_HG-U133A	PDGFRA VCAN FAM210B HUWE1 BSN SEZ6L	2.17e-05	195	66	6	6761_UP
Drug	Quinidine hydrochloride monohydrate [6151-40-2]; Up 200; 10.6uM; PC3; HT_HG-U133A	SHANK2 ACAN KMT2A HUWE1 SEZ6L DOP1A	2.23e-05	196	66	6	5793_UP
Drug	Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A	TPR KMT2A QSER1 RFX7 WNK1 HCFC1	2.29e-05	197	66	6	3748_DN
Drug	Sulfamethizole [144-82-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A	RALGAPA1 LLGL1 SHANK2 ACAN VCAN MUC5B	2.29e-05	197	66	6	6099_UP
Drug	Progesterone [57-83-0]; Up 200; 12.8uM; MCF7; HT_HG-U133A	PDGFRA ACAN TP63 KMT2A PAX5 SEZ6L	2.29e-05	197	66	6	4992_UP
Drug	Nicergoline; Down 200; 8.2uM; HL60; HG-U133A	TPR PPRC1 ACAN TMF1 TNKS2 RFX7	2.29e-05	197	66	6	1374_DN
Drug	WY-14643; Up 200; 100uM; PC3; HG-U133A	LPIN1 ACAN DTX4 TMF1 WNK1 SEZ6L	2.29e-05	197	66	6	464_UP
Drug	Trimipramine maleate salt [521-78-8]; Up 200; 9.8uM; HL60; HT_HG-U133A	RALGAPA1 LPIN1 KMT2A PAX5 HUWE1 WNK1	2.36e-05	198	66	6	3004_UP
Drug	Stachydrine hydrochloride; Down 200; 22.2uM; HL60; HG-U133A	DENND4A PPRC1 TMF1 KMT2A TNKS2 HCFC1	2.43e-05	199	66	6	1751_DN
Drug	dinophysistoxin-4	DTX1 DTX4	2.48e-05	3	66	2	CID006441267
Drug	Phentolamine hydrochloride [73-05-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A	FBXL7 LLGL1 SHANK2 ACAN ARHGEF38 SEZ6L	2.50e-05	200	66	6	2323_UP
Drug	Carcinine [56897-53-1]; Up 200; 22uM; MCF7; HT_HG-U133A	VCAN FAM210B ALPK3 PAX5 WNK1 HCFC1	2.50e-05	200	66	6	4809_UP
Drug	yessotoxin	DTX1 VCAN DTX2	4.51e-05	24	66	3	CID006440821
Drug	9-chloromethylanthracene	DTX1 DTX2	4.95e-05	4	66	2	CID000032385
Drug	AC1O58I7	ACAN VCAN	4.95e-05	4	66	2	CID006453989
Drug	AC1L8NVO	DTX1 DTX2	8.23e-05	5	66	2	CID000384632
Drug	LS-185883	DTX1 DTX2	8.23e-05	5	66	2	CID006442214
Drug	dinophysistoxin-1	DTX1 DTX4 DTX2	9.87e-05	31	66	3	CID006437058
Drug	1-bromoacetylpyrene	DTX1 DTX2	1.23e-04	6	66	2	CID000133483
Drug	eg D	CMTR1 MUC12 WNK1	1.31e-04	34	66	3	CID000029544
Drug	Rifabutin [72559-06-9]; Down 200; 4.8uM; MCF7; HT_HG-U133A	SETDB1 BRINP3 PAX5 QSER1 HCFC1	1.55e-04	175	66	5	3873_DN
Drug	cellobiitol	MUC12 MUC3A MUC4	1.68e-04	37	66	3	CID000003871
Drug	rosiglitazone; Up 200; 10uM; PC3; HT_HG-U133A	LPIN1 LLGL1 PDGFRA OSBPL3 DTX4	1.81e-04	181	66	5	4457_UP
Drug	Dobutamine hydrochloride [49745-95-1]; Up 200; 11.8uM; PC3; HT_HG-U133A	RALGAPA1 PAPOLA VCAN MUC5B HUWE1	2.01e-04	185	66	5	6286_UP
Drug	Rapamycin; Up 200; 0.1uM; PC3; HT_HG-U133A	PDGFRA VCAN ALPK3 NAV2 MUC5B	2.11e-04	187	66	5	1242_UP
Drug	Dicyclomine hydrochloride [67-92-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A	ACAN TP63 KMT2A HUWE1 HCFC1	2.16e-04	188	66	5	4405_UP
Drug	benz(a)anthracene	MKKS TPR LPIN1 PAPOLA DNAH10 OSBPL3 DTX4 FNBP4 ARHGEF38 IRF2BPL MUC4 BRWD1	2.24e-04	1251	66	12	ctd:C030935
Drug	Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A	TPR BRINP3 SALL2 FAM210B OSBPL11	2.27e-04	190	66	5	2619_DN
Drug	Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A	TPR ARHGEF38 KMT2A RFX7 WNK1	2.27e-04	190	66	5	4322_DN
Drug	Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT_HG-U133A	TPR FAM210B KMT2A RFX7 WNK1	2.33e-04	191	66	5	4269_DN
Drug	Naphazoline hydrochloride [550-99-2]; Down 200; 16.2uM; PC3; HT_HG-U133A	RALGAPA1 LPIN1 PAPOLA VCAN KMT2A	2.44e-04	193	66	5	6604_DN
Drug	Prednicarbate [73771-04-7]; Down 200; 8.2uM; PC3; HT_HG-U133A	DENND4A VCAN FAM210B KMT2A QSER1	2.44e-04	193	66	5	5119_DN
Drug	PF-00562151-00 [351320-12-2]; Up 200; 10uM; MCF7; HT_HG-U133A	TP63 VCAN FAM210B NAV2 PAX5	2.44e-04	193	66	5	6868_UP
Drug	AC1L18R8	MTOR TP63 VCAN DTX2	2.47e-04	105	66	4	CID000050261
Drug	H-89, Dihydrochloride; Up 200; 0.5uM; PC3; HT_HG-U133A	SETDB1 MTOR OSBPL3 KMT2A WNK1	2.50e-04	194	66	5	6921_UP
Drug	Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A	TPR KMT2A TNKS2 WNK1 HCFC1	2.50e-04	194	66	5	4727_DN
Drug	2-propylpentanoic acid; Down 200; 1000uM; PC3; HG-U133A	SETDB1 ACAN TP63 MUC5B SEZ6L	2.50e-04	194	66	5	433_DN
Drug	ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A	SHANK2 VCAN FAM210B TNKS2 WNK1	2.56e-04	195	66	5	7539_DN
Drug	Mefenamic acid [61-68-7]; Down 200; 16.6uM; PC3; HT_HG-U133A	SETDB1 DENND4A FBXL7 TNKS2 WNK1	2.56e-04	195	66	5	5109_DN
Drug	Picrotoxinin [17617-45-7]; Down 200; 13.6uM; PC3; HT_HG-U133A	SETDB1 DENND4A FBXL7 PDGFRA FAM210B	2.56e-04	195	66	5	4260_DN
Drug	Torsemide [56211-40-6]; Down 200; 11.4uM; HL60; HT_HG-U133A	MTOR DTX4 QSER1 WNK1 HCFC1	2.56e-04	195	66	5	2956_DN
Drug	nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HG-U133A	PPRC1 ACAN FAM210B ARHGEF38 WNK1	2.62e-04	196	66	5	203_DN
Drug	Sulfadimethoxine [122-11-2]; Up 200; 12.8uM; MCF7; HT_HG-U133A	RALGAPA1 LPIN1 QSER1 WNK1 HCFC1	2.62e-04	196	66	5	4724_UP
Drug	Ivermectin [70288-86-7]; Down 200; 4.6uM; HL60; HG-U133A	ACAN SERINC3 TNKS2 RFX7 HCFC1	2.62e-04	196	66	5	1367_DN
Drug	Demecarium bromide [56-94-0]; Down 200; 5.6uM; PC3; HT_HG-U133A	TPR SETDB1 FBXL7 VCAN TNKS2	2.62e-04	196	66	5	5795_DN
Drug	Molindone hydrochloride [15622-65-8]; Up 200; 12.8uM; PC3; HT_HG-U133A	RALGAPA1 LPIN1 SETDB1 SHANK2 TP63	2.69e-04	197	66	5	4199_UP
Drug	Sulfadiazine [68-35-9]; Down 200; 16uM; PC3; HT_HG-U133A	LPIN1 FBXL7 DTX4 VCAN FAM210B	2.69e-04	197	66	5	5098_DN
Drug	Dichlorphenamide [120-97-8]; Down 200; 13.2uM; PC3; HT_HG-U133A	RALGAPA1 DENND4A FBXL7 WNK1 BRWD1	2.69e-04	197	66	5	6686_DN
Drug	estradiol, USP; Down 200; 0.1uM; PC3; HT_HG-U133A	TPR SETDB1 FBXL7 PPRC1 TNKS2	2.69e-04	197	66	5	1208_DN
Drug	Ganciclovir [82410-32-0]; Down 200; 15.6uM; PC3; HT_HG-U133A	TPR SETDB1 SHANK2 TNKS2 HCFC1	2.69e-04	197	66	5	6289_DN
Drug	Succinylsulfathiazole [116-43-8]; Down 200; 11.2uM; PC3; HT_HG-U133A	RALGAPA1 LPIN1 SETDB1 FAM210B QSER1	2.69e-04	197	66	5	4265_DN
Drug	Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; PC3; HT_HG-U133A	TPR LPIN1 SHANK2 VCAN BRWD1	2.69e-04	197	66	5	5746_DN
Drug	Paromomycin sulfate [1263-89-4]; Up 200; 5.6uM; HL60; HT_HG-U133A	RALGAPA1 LLGL1 TP63 HUWE1 MUC4	2.75e-04	198	66	5	3017_UP
Drug	Ticarcillin sodium [4697-14-7]; Up 200; 9.4uM; PC3; HT_HG-U133A	FBXL7 LLGL1 FAM210B PAX5 BRWD1	2.75e-04	198	66	5	5829_UP
Drug	Ribostamycin sulfate salt [53797-35-6]; Up 200; 7.2uM; MCF7; HT_HG-U133A	RALGAPA1 DENND4A VCAN WNK1 HCFC1	2.75e-04	198	66	5	6765_UP
Drug	Bromperidol [10457-90-6]; Up 200; 9.6uM; HL60; HG-U133A	OSBPL3 ACAN ARHGEF38 OSBPL11 HCFC1	2.75e-04	198	66	5	1723_UP
Drug	Mephenesin [59-47-2]; Up 200; 22uM; MCF7; HT_HG-U133A	ACAN ARHGEF38 MYOM2 MUC4 SEZ6L	2.75e-04	198	66	5	2304_UP
Drug	Adenosine 5'-monophosphate monohydrate [18422-05-4]; Up 200; 11uM; MCF7; HT_HG-U133A	SHANK2 ACAN VCAN FAM210B MUC5B	2.75e-04	198	66	5	3237_UP
Drug	paclitaxel; Up 200; 0.1uM; MCF7; HG-U133A	LLGL1 ACAN TP63 KMT2A WNK1	2.75e-04	198	66	5	640_UP
Drug	Chlorambucil [305-03-3]; Up 200; 13.2uM; MCF7; HT_HG-U133A	FBXL7 LLGL1 VCAN PAX5 SEZ6L	2.75e-04	198	66	5	4345_UP
Drug	Nifenazone [2139-47-1]; Up 200; 13uM; MCF7; HT_HG-U133A	ACAN VCAN PAX5 HCFC1 SEZ6L	2.75e-04	198	66	5	2285_UP
Drug	Aspartic acid, N-acetyl (R,S) [997-55-7]; Up 200; 22.8uM; PC3; HT_HG-U133A	LPIN1 SETDB1 FAM210B WNK1 HCFC1	2.75e-04	198	66	5	4007_UP
Drug	Gabapentin [60142-96-3]; Up 200; 23.4uM; PC3; HT_HG-U133A	RALGAPA1 TPR WNK1 SEZ6L BRWD1	2.75e-04	198	66	5	5875_UP
Drug	Flufenamic acid [530-78-9]; Down 200; 14.2uM; PC3; HT_HG-U133A	SETDB1 DENND4A VCAN FAM210B HCFC1	2.75e-04	198	66	5	5059_DN
Drug	Chlorpropamide [94-20-2]; Up 200; 14.4uM; PC3; HT_HG-U133A	SETDB1 BRINP3 FBXL7 PAPOLA ACAN	2.75e-04	198	66	5	6291_UP
Drug	Famprofazone [22881-35-2]; Up 200; 10.6uM; PC3; HT_HG-U133A	LLGL1 PDGFRA TP63 ALPK3 DOP1A	2.75e-04	198	66	5	3753_UP
Drug	genistein; Down 200; 1uM; MCF7; HG-U133A	ACAN TP63 HUWE1 SEZ6L DOP1A	2.81e-04	199	66	5	267_DN
Drug	Dirithromycin [62013-04-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A	LPIN1 FBXL7 LLGL1 SHANK2 SEZ6L	2.81e-04	199	66	5	7446_UP
Drug	Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; MCF7; HT_HG-U133A	PAPOLA TP63 PAX5 WNK1 HCFC1	2.81e-04	199	66	5	3608_DN
Drug	Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; PC3; HT_HG-U133A	TPR VCAN QSER1 DOP1A BRWD1	2.81e-04	199	66	5	4316_DN
Drug	Medrysone [2668-66-8]; Up 200; 11.6uM; MCF7; HT_HG-U133A	PDGFRA OSBPL3 ACAN HUWE1 MUC4	2.81e-04	199	66	5	3603_UP
Drug	Metanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; PC3; HG-U133A	TPR SETDB1 ATP6V1H PAPOLA KMT2A	2.81e-04	199	66	5	1933_DN
Drug	Mephenesin [59-47-2]; Up 200; 22uM; PC3; HT_HG-U133A	RALGAPA1 LPIN1 SETDB1 DENND4A SEZ6L	2.81e-04	199	66	5	7374_UP
Drug	Bethanechol chloride [590-63-6]; Up 200; 20.4uM; MCF7; HT_HG-U133A	LPIN1 FBXL7 ACAN ARHGEF38 WNK1	2.81e-04	199	66	5	5539_UP
Drug	FK-506; Down 200; 1uM; MCF7; HG-U133A	ACAN TP63 VCAN FAM210B WNK1	2.81e-04	199	66	5	284_DN
Drug	Tolbutamide [64-77-7]; Up 200; 14.8uM; MCF7; HT_HG-U133A	RALGAPA1 VCAN ARHGEF38 KMT2A PAX5	2.81e-04	199	66	5	2320_UP
Drug	colchicine; Down 200; 0.1uM; MCF7; HG-U133A	RALGAPA1 LPIN1 KMT2A PAX5 WNK1	2.81e-04	199	66	5	644_DN
Drug	Spiramycin [8025-81-8]; Up 200; 4.8uM; HL60; HT_HG-U133A	TP63 VCAN NAV2 KMT2A HUWE1	2.88e-04	200	66	5	2558_UP
Drug	cobalt(II) chloride hexahydrate; Up 200; 100uM; MCF7; HG-U133A	TPR OSBPL3 ACAN QSER1 HUWE1	2.88e-04	200	66	5	383_UP
Drug	dinophysistoxin-2	DTX1 DTX2	2.94e-04	9	66	2	CID006437082
Drug	trofosfamide	VCAN TMF1 MUC4	3.67e-04	48	66	3	CID000065702
Drug	AC1LAJ7C	SHANK2 HUWE1	3.67e-04	10	66	2	CID000469401
Drug	9-anthryldiazomethane	DTX1 DTX2	3.67e-04	10	66	2	CID003035201
Disease	cholangiocarcinoma (is_marker_for)	MUC16 MUC5B MUC3A MUC4	1.31e-05	64	66	4	DOID:4947 (is_marker_for)
Disease	Precursor B-cell lymphoblastic leukemia	PDGFRA KMT2A PAX5	1.38e-05	21	66	3	C1292769
Disease	Burkitt Lymphoma	PDGFRA KMT2A PAX5	7.24e-05	36	66	3	C0006413
Disease	triglyceride measurement, intermediate density lipoprotein measurement	DNAH10 TNKS2 PCSK9 BRWD1	1.14e-04	111	66	4	EFO_0004530, EFO_0008595
Disease	otitis media (is_marker_for)	MUC5B MUC4	2.19e-04	10	66	2	DOID:10754 (is_marker_for)
Disease	plasminogen activator inhibitor 1 measurement	MYOM2 MUC12 RFX7	2.44e-04	54	66	3	EFO_0004792
Disease	Metastatic melanoma	PDGFRA MTOR ALPK3	2.44e-04	54	66	3	C0278883
Disease	pancreatic ductal carcinoma (is_marker_for)	MUC5B MUC3A MUC4	3.51e-04	61	66	3	DOID:3587 (is_marker_for)
Disease	triglyceride measurement, low density lipoprotein cholesterol measurement	DNAH10 TNKS2 PCSK9 BRWD1	5.31e-04	166	66	4	EFO_0004530, EFO_0004611
Disease	endoplasmic reticulum resident protein 29 measurement	MUC21 MUC22	5.79e-04	16	66	2	EFO_0020346
Disease	HIV-1 infection, Susceptibility to viral and mycobacterial infections	NAV2 PAX5	1.01e-03	21	66	2	EFO_0000180, Orphanet_391311
Disease	Hepatitis	NAV2 ANKRD50	1.11e-03	22	66	2	HP_0012115
Disease	clinical and behavioural ideal cardiovascular health	BRINP3 PCSK9	1.21e-03	23	66	2	EFO_0007654
Disease	Sjogren's syndrome (is_marker_for)	MUC19 MUC16	1.32e-03	24	66	2	DOID:12894 (is_marker_for)
Disease	Carcinoma, Pancreatic Ductal	DTX1 DTX4	1.32e-03	24	66	2	C0887833
Disease	unipolar depression	MUC21 BRINP3 SHANK2 FMN1 VCAN ALPK3 MUC5B PAX5 QSER1	1.41e-03	1206	66	9	EFO_0003761
Disease	complement C4b measurement	MUC21 MUC22	1.43e-03	25	66	2	EFO_0008092
Disease	very low density lipoprotein cholesterol measurement, lipid measurement	DNAH10 TNKS2 PCSK9 BRWD1	1.51e-03	220	66	4	EFO_0004529, EFO_0008317
Disease	pancreatic cancer (is_marker_for)	PDGFRA MUC16 MUC4	1.52e-03	101	66	3	DOID:1793 (is_marker_for)
Disease	Antiglaucoma preparations and miotics use measurement	FNBP4 KMT2A	1.55e-03	26	66	2	EFO_0009944
Disease	very low density lipoprotein cholesterol measurement, phospholipid measurement	DNAH10 TNKS2 PCSK9 BRWD1	1.75e-03	229	66	4	EFO_0004639, EFO_0008317
Disease	functional brain measurement, language measurement	DACT1 SEZ6	1.79e-03	28	66	2	EFO_0007797, EFO_0007849
Disease	free cholesterol measurement	LLGL1 FNBP4 PCSK9	2.10e-03	113	66	3	EFO_0008591
Disease	eicosapentaenoic acid measurement	NAV2 MUC22	2.20e-03	31	66	2	EFO_0007760

Protein segments in the cluster

Peptide	Gene	Start	Entry
EGSDSTTNSSSVTLE	BRINP3	161	Q76B58
ETEGSSTTGFTSSLS	VCAN	1141	P13611
SQTDIFEGSGSVTST	VCAN	2316	P13611
DSVTGTSESSIGDSS	ARHGEF38	676	Q9NXL2
SASSSSDVASIGVST	ALPK3	766	Q96L96
IGSTSSETETASTVG	DOP1A	631	Q5JWR5
TEGEQTSTSLSGTVA	ANKRD50	201	Q9ULJ7
IFAIGTSSTTGESDT	DTX4	556	Q9Y2E6
TTTATTTGATGSVAT	MUC5B	2581	Q9HC84
TATATTTGATGSVAT	MUC5B	4566	Q9HC84
TSLSSVGAQDSESTS	DENND4A	1356	Q7Z401
NTTGTATTSSTTVGA	QSER1	1276	Q2KHR3
GETASISSVSASAEG	FMN1	401	Q68DA7
TGSVTQVSSVSTDSA	PAX5	161	Q02548
ATSADTTLDTTGDVT	LLGL1	1016	Q15334
SSQTSEESAIETGSS	PDGFRA	1041	P16234
ETHETGTTNTATTAT	HCFC1	1081	P51610
ETGTTHTATTATSNG	HCFC1	1326	P51610
SSVLSESTTEGVTDS	MUC16	1701	Q8WXI7
ESTTEGVTDSSKGSS	MUC16	1706	Q8WXI7
SSTSVFGSSETTEIE	MUC16	4286	Q8WXI7
TGSSVETSSAIETSA	MUC16	7251	Q8WXI7
RTVTDVGTSSSGHES	MUC16	8056	Q8WXI7
VDTSLGTESSTTEGR	MUC16	10361	Q8WXI7
STGSTTATLEGQSTA	MUC4	46	Q99102
TTSTDSTLGNTEETS	MUC4	141	Q99102
VTDTSSASTGDTTSL	MUC4	2691	Q99102
VTDTSSASTGDTTSL	MUC4	3251	Q99102
TTLSGDTSDTGEGTV	MKKS	246	Q9NPJ1
SVTISCTGTSSDVGD	IGLV2-33	36	A0A075B6J2
EGTSGNVTFTSSATT	HSFX4	271	A0A1B0GTS1
SVTSSGVSTATISGS	MUC21	51	Q5SSG8
GISTATNSEFSTVSS	MUC21	86	Q5SSG8
FTKGSDTTTASITGS	MUC22	31	E2RYF6
TGSKITTDSTTGSET	MUC22	61	E2RYF6
AFTTGSETNTASTTD	MUC22	86	E2RYF6
SETNTASTTDSGTTI	MUC22	91	E2RYF6
ASTRTFTTGSDTTTG	MUC22	106	E2RYF6
DTTTGSTAGSETIVA	MUC22	116	E2RYF6
TGSETATVSTTGSET	MUC22	181	E2RYF6
TGSETTTASTAGSET	MUC22	211	E2RYF6
SISGSEITTTSTAGS	MUC22	311	E2RYF6
ENTTVSSAGSGTTTA	MUC22	326	E2RYF6
GTTTASMAGSETTVS	MUC22	336	E2RYF6
ETTVSTAGSETTTVS	MUC22	346	E2RYF6
TAGSETTTVSITGTE	MUC22	351	E2RYF6
TAGSETTTVSTVGSE	MUC22	391	E2RYF6
TAGSETTTVSTAGSE	MUC22	441	E2RYF6
TAGSETTTVSTTGSE	MUC22	451	E2RYF6
TTGSETTTASTAHSE	MUC22	461	E2RYF6
TAGSETTVSTAGSET	MUC22	491	E2RYF6
EDSKTTTASTTGFET	MUC22	521	E2RYF6
VGSETTTVSTTGSET	MUC22	591	E2RYF6
TGSETTTASIMGSET	MUC22	601	E2RYF6
MGSETSTDSTTGSET	MUC22	611	E2RYF6
TGSETTTASTEGSET	MUC22	621	E2RYF6
EGSETTTASTEGSEA	MUC22	631	E2RYF6
TTASTEGSEATTVST	MUC22	636	E2RYF6
EGSEATTVSTTGSET	MUC22	641	E2RYF6
TGSETTTVSITDSET	MUC22	651	E2RYF6
TTASTEGSEITIAST	MUC22	686	E2RYF6
EGSETTTVTTAGSET	MUC22	711	E2RYF6
TGSETTTASNTGLET	MUC22	731	E2RYF6
IGSDTTTASTEGSET	MUC22	751	E2RYF6
TTASTEGSETTAVSA	MUC22	756	E2RYF6
EGSENTTVSTTGSET	MUC22	781	E2RYF6
TGSETTTVSTTGLET	MUC22	791	E2RYF6
TGAETTTDSTEGSGT	MUC22	821	E2RYF6
TTDSTEGSGTTAAST	MUC22	826	E2RYF6
EGSETTTVSTTDSET	MUC22	891	E2RYF6
TGSERTITSTEGSET	MUC22	911	E2RYF6
EGSETTTVSATGSET	MUC22	921	E2RYF6
TTVSATGSETTVSTE	MUC22	926	E2RYF6
TGSETTVSTEGSGTT	MUC22	931	E2RYF6
TVSTEGSGTTTVSIT	MUC22	936	E2RYF6
GSGTTTVSITGSETT	MUC22	941	E2RYF6
GSETTKVSTTGSETT	MUC22	951	E2RYF6
GSETTTTSTEGSEIT	MUC22	961	E2RYF6
GSEITTASITGSETT	MUC22	971	E2RYF6
TASITGSETTTASTE	MUC22	976	E2RYF6
GSETTTASTEGSETT	MUC22	981	E2RYF6
TASTEGSETTTASTE	MUC22	986	E2RYF6
GSETTTASTEGSETT	MUC22	991	E2RYF6
GSETTSASTTGSETT	MUC22	1001	E2RYF6
GSETTMASTIGSETT	MUC22	1031	E2RYF6
ASETTTVSTAGSETI	MUC22	1071	E2RYF6
GSETTTTTSTEGSET	MUC22	1091	E2RYF6
EGSETTTASTEGSET	MUC22	1101	E2RYF6
ESSETTTATTIGSET	MUC22	1121	E2RYF6
IGSETTTASTEGSET	MUC22	1131	E2RYF6
EGSETTTTSTEGSET	MUC22	1141	E2RYF6
EGSETTTASTEGSEI	MUC22	1151	E2RYF6
EGSEITTVSTTGSET	MUC22	1161	E2RYF6
TGSETTTASTEGSET	MUC22	1171	E2RYF6
EGSETTTASTEGSEL	MUC22	1181	E2RYF6
TTASTEGSELTTVST	MUC22	1186	E2RYF6
EGSELTTVSTTGSET	MUC22	1191	E2RYF6
TGSETITVSAEGSET	MUC22	1201	E2RYF6
EGSETTTVTTMGSET	MUC22	1211	E2RYF6
AGSETTTVSTAGSET	MUC22	1231	E2RYF6
AGSETTTASIEGSET	MUC22	1241	E2RYF6
TTASIEGSETTTVSS	MUC22	1246	E2RYF6
EGSETTTVSSTGSET	MUC22	1251	E2RYF6
TGSETTTVSTTGTET	MUC22	1261	E2RYF6
TGTETTITSTEGSET	MUC22	1271	E2RYF6
EGSETTTVTTAGSET	MUC22	1281	E2RYF6
TGSETTTTSTEGSET	MUC22	1301	E2RYF6
EGSETTTVSTTGSET	MUC22	1311	E2RYF6
TGSETTTASTADLET	MUC22	1321	E2RYF6
ADLETTTVSTSGSGT	MUC22	1331	E2RYF6
TGSKTTTASTEGSEA	MUC22	1361	E2RYF6
TTASTEGSEATTVST	MUC22	1366	E2RYF6
EGSEATTVSTTSSET	MUC22	1371	E2RYF6
AGSEATTTSTEGSET	MUC22	1421	E2RYF6
EGSETTTASTAGSET	MUC22	1431	E2RYF6
AGSETTTASTAGSET	MUC22	1441	E2RYF6
AGSETTTASTSGSET	MUC22	1451	E2RYF6
SGSETNTACTTGSET	MUC22	1461	E2RYF6
TGSETTTVSITASGA	MUC22	1511	E2RYF6
IFTVGTSSTTGETDT	DTX2	561	Q86UW9
SSDGISSSQSEITGV	BSN	686	Q9UPA5
SITISCTGTSSDVGS	IGLV2-23	36	P01705
SASSSTSSSVAEVGV	IRF2BPL	311	Q9H1B7
VRSRDVSTTGSTSEG	PCSK9	656	Q8NBP7
VTGVVSSSSTFTAGE	FAT2	1296	Q9NYQ8
GSTEGSVEATTSAGS	MUC19	1901	Q7Z5P9
SETTESSAGVIVTSG	MUC19	2486	Q7Z5P9
ITGSSVKESGTTESS	MUC19	3206	Q7Z5P9
ITGLSDVVTETTGSS	MUC19	3576	Q7Z5P9
DVVTETTGSSARSGT	MUC19	3581	Q7Z5P9
VTETTGSSARSGTSI	MUC19	4101	Q7Z5P9
SVGETGTTRTSVEES	MUC19	4426	Q7Z5P9
TGKTGTTRTSVEEST	MUC19	5886	Q7Z5P9
SSTEATTSIGGSAST	MUC19	6261	Q7Z5P9
RATGATTSIVGSDTS	MUC19	6801	Q7Z5P9
TGAETITEATTSTEG	MUC19	7046	Q7Z5P9
ITEATTSTEGTGTSG	MUC19	7051	Q7Z5P9
SGSSNTEATTSTEGT	MUC19	7201	Q7Z5P9
TEATTSTEGTGTSGT	MUC19	7206	Q7Z5P9
GTTVASGSSNSEATT	MUC19	7756	Q7Z5P9
GSSSTEATTSTGVHR	MUC19	7851	Q7Z5P9
SSTVATTGTGQTTFT	MUC3A	1716	Q02505
QATGTTGSSVSCTEE	FAM210B	66	Q96KR6
SVGSSGVDSGVESTS	LPIN1	441	Q14693
SVTISCTGTSSDVGS	IGLV2-18	36	A0A075B6J9
EGTSGNVTFTSSATT	HSFX3	271	A0A1B0GWH4
TETSASGTSQGEAST	HUWE1	2021	Q7Z6Z7
FTIGTSNTTGESDTV	DTX1	561	Q86Y01
SGSGESSGITFVDTS	ACAN	1821	P16112
EVSGESTTTSDVGTE	ACAN	2166	P16112
VNSSESSGGTSSESI	PAPOLA	581	P51003
SSASTVSVGSSETRG	TP63	621	Q9H3D4
FVGESTTTSDSEESG	DACT1	766	Q9NYF0
RGSSTSSSSITGETV	FBXL7	71	Q9UJT9
ISSGVTSGDSSDSAE	BRWD1	1496	Q9NSI6
SGTDITSVTLGDTTA	KMT2A	941	Q03164
SVSTTGTATDLESSA	KMT2A	2226	Q03164
TTVGVTSGEVSNSSE	DNAH10	161	Q8IVF4
SEGSAISGVAESSTA	SALL2	531	Q9Y467
AAFSSSSESGVTTTI	SLC39A12	561	Q504Y0
SSSRGQSTVGTEVTS	PPRC1	481	Q5VV67
STTSLSGSDSETEGK	CMTR1	46	Q8N1G2
STITDSSSGVFDSIS	OSBPL3	166	Q9H4L5
SEVASSVFSSSSTQG	OSBPL11	466	Q9BXB4
ATATTTASTEGSNSE	MTOR	1836	P42345
HETGTSSDSTSSVLG	RSBN1L	706	Q6PCB5
GVAVETGTVSSSDSS	ATP6V1H	181	Q9UI12
TGSASEESQETTTST	SEZ6L	251	Q9BYH1
GTDSNSTESSETSTG	FNBP4	656	Q8N3X1
TEGNVTAESSSTGVS	NAV2	706	Q8IVL1
TLSSSTESEGESGTS	SETDB1	1101	Q15047
STVSSISTLSSEGGE	SHANK2	1511	Q9UPX8
VSTFSSGTSTTSDIE	TMF1	246	P82094
FGTDTAGVTTTSGST	UBN2	1276	Q6ZU65
TDTGVTSSADVDSGS	RALGAPA1	931	Q6GYQ0
TSTGTLSTTNETATG	TPR	2246	P12270
TASGDDEETTTTTTI	SEZ6	216	Q53EL9
ASVSSATGTTEESRS	RFX7	396	Q2KHR2
LSGSDSVILGDTTTS	SERINC3	366	Q13530
SDSGSESVSFTDGSV	YTHDC1	271	Q96MU7
GSFSELSSVVSSSGT	TNKS2	846	Q9H2K2
LSSVVSSSGTEGASS	TNKS2	851	Q9H2K2
STSSVSSQGSISEGD	SH3RF2	461	Q8TEC5
VTVSATSASAGGSTA	WNK1	1451	Q9H4A3
ESDTTSGRGEESTTS	MUC12	846	Q9UKN1
ESDTTSGRGEESTTS	MUC12	3486	Q9UKN1
SVSVSDTDGVSSSFV	MYOM2	981	P54296